GLP-1RAs are synthetic molecules that mimic the effects of the naturally-occurring GLP-1 hormone, including increasing insulin secretion and slowing gastric emptying
second, focusing on high-risk cohorts, such as patients with MASH-related compensated cirrhosis, using dynamic contrast-enhanced ultrasound (DCE-US) to monitor de novo nodule emergence and evolution (e.g., arterial phase hyperenhancement) as surrogate endpoints for preliminary chemopreventive assessment
Because of this, early weight loss on GLP-1 therapy is often considered clinically meaningful, even if it appears modest on the scale
What positive factors might skew risk-reward in a favorable direction from this base
GNC has a GLP-1 support program across all of its stores
Before use, all solutions were sterilized by filtration through 0.2-m membrane filters